W

WPSS.bio

North America, New York, United States, New York

Description

WPSS.bio is a venture capital firm that invests in revolutionary diagnostics and treatments for central nervous system health.

Investor Profile

WPSS.bio has made 22 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (32%)
  • Convertible Note (27%)
  • Series A (18%)
  • Series B (9%)
  • Undisclosed (5%)
  • Pre Seed (5%)
  • Secondary Market (5%)

Country Focus

  • United States (86%)
  • United Kingdom (9%)
  • Germany (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Mental Health
  • Therapeutics
  • Pharmaceutical
  • Medical Device
  • Neuroscience
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does WPSS.bio frequently co-invest with?

Two Sigma Ventures
North America, New York, United States, New York
Co-Investments: 1
Bossa Invest
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 1
8VC
North America, California, United States, San Francisco
Co-Investments: 1
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 3
Freeflow Ventures
North America, California, United States, Pasadena
Co-Investments: 1
Sherpa Healthcare Partners
Asia, Beijing, China, Beijing
Co-Investments: 1
PS
North America, Illinois, United States, Highland Park
Co-Investments: 3
Able Partners
North America, New York, United States, New York
Co-Investments: 1
re.Mind Capital
Europe, NA - Malta, Malta, Sliema
Co-Investments: 3
Route 66 Ventures
North America, Virginia, United States, Alexandria
Co-Investments: 2

Which angels does WPSS.bio often collaborate with?

LG
North America, California, United States, San Francisco
Shared Deals: 1
HG
North America, United States
Shared Deals: 1
JL
North America, Massachusetts, United States, Boston
Shared Deals: 1
AK
North America, New York, United States, Brooklyn
Shared Deals: 1
AK
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by WPSS.bio?

Gilgamesh Pharmaceuticals

New York, New York, United States

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series BDec 15, 2022
Amount Raised: $39,000,000
Sensorium Therapeutics

Boston, Massachusetts, United States

Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines.

Health CareMedicalTherapeutics
Series AOct 4, 2022
Amount Raised: $30,000,000
Cordance Medical

Mountain View, California, United States

Cordance Medical develops radical therapy for a variety of CNS pathology.

Health CareMedical DeviceTherapeutics
SeedAug 1, 2022
Osmind

San Francisco, California, United States

Osmind is the premier technology platform for breakthough mental health treatment and research.

Health CareMedicalMental Health
Series BMay 10, 2022
Amount Raised: $40,000,000
Blackrock Neurotech

Salt Lake City, Utah, United States

Blackrock Neurotech is the platform for brain-computer interface (BCI) technology and manufacturing.

Machinery ManufacturingMedical DeviceNeuroscience
Convertible NoteNov 1, 2021
Kanna Health

Sevenoaks, Kent, United Kingdom

Developing novel therapeutics from the kanna plant

Biotechnology
Pre SeedOct 31, 2021
Amount Raised: $6,157,349
Ceretype Neuromedicine

Cambridge, Massachusetts, United States

Ceretype Neuromedicine is a next-generation fMRI brain biomarker platform to improve drug discovery and patient care in neuropsychiatry

BiotechnologyHealth CareLife ScienceMachine LearningMedical
Convertible NoteOct 6, 2021
Ksana Health

Eugene, Oregon, United States

Ksana Health focuses on collecting data related to mental health and transfer it from users to healthcare practitioners through an app.

AppsHealth CareMedicalMental Health
SeedJun 16, 2021
Amount Raised: $2,000,000
Appia Bio

Los Angeles, California, United States

Appia Bio is a biotechnology company that focuses on the research and development of off-the-shelf allogeneic cell therapies.

BiotechnologyHealth CareLife SciencePharmaceutical
Series AMay 11, 2021
Amount Raised: $52,000,000
Eikon Therapeutics

Hayward, California, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

BiotechnologyHealth CareLife ScienceMedical
Series AMay 5, 2021
Amount Raised: $148,000,000